ZOE — AI-personalised nutrition (microbiome + glucose) consumer product, US launch

NA-USA (and UK home market)

Content

ZOE is a consumer nutrition product that combines at-home gut-microbiome testing, continuous glucose monitoring (via a CGM partner), and an AI-driven personalisation app to deliver individual food scores and dietary recommendations. The product runs in the UK (home market) and the United States (active market). The current generation (ZOE 2.0, live in 2025) uses advanced AI photologging for food intake tracking.

ZOE’s research arm publishes in peer-reviewed venues (e.g. AJCN on the PREDICT study series) and partners with academic institutions including King’s College London, Stanford, and Harvard T.H. Chan School of Public Health. The product is positioned as science-led but is commercial.

What this unit is doing in the taxonomy

The most prominent consumer nutrition AI product in the US that combines microbiome data, glucose data, and AI personalisation. Anchors the consumer nutrition × AI cell, parallel to (but distinct from) Levels Health (CGM-only) and MyFitnessPal (logging-only).

Why it matters for talks

• Documents a consumer health-data AI deployment that is largely outside FDA medical-device scope (ZOE positions its product as wellness, not medical). The line between wellness AI and medical AI is consequential for regulatory framing.
• The microbiome-data component is uniquely personal biological data — its collection, retention, and downstream use raises data-governance questions that ZOE’s published privacy materials address but that are not auditable by users.
• Peer-reviewed research backing gives ZOE more scientific credibility than most consumer nutrition AI products, but the commercial product behaviour (recommendations, food scores) is not the same as the study outcomes.

Critical context the unit does not sanitise

• Consumer microbiome data is a new category of personal biological data. ZOE’s data-retention and secondary-use policies are vendor-defined, not publicly regulated.
• The ZOE food scores are proprietary and not independently verifiable. A consumer receiving a “good” or “bad” food score from ZOE is taking the vendor’s model at face value.
• The product is priced out of reach for low-income consumers (subscription + CGM + microbiome kit). This is a digital-equity concern.